André Choulika
Founder en CELLECTIS S.A. .
Fortuna: 3 M $ al 31/03/2024
Perfil
André Choulika is the founder.
He founded Cellectis SA in 1999 and currently holds the title of Chief Executive Officer & Director.
He also founded Calyxt, Inc. in 2010 and served as Chairman until 2020.
In addition to his founding positions, Dr. Choulika currently holds several other roles.
Since 2014, he has been the Chairman & Chief Executive Officer of Cellectis, Inc. He also serves as Chairman & Chief Executive Officer of Cellectis Biologics, Inc. since 2019.
Furthermore, Dr. Choulika is the Director of Institut Pasteur and a Director of the France Biotech Association.
Previously, Dr. Choulika held a position as Director at Takara Bio Europe AB.
Dr. Choulika obtained his doctorate degree from Université Pierre et Marie Curie in 1995.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
CELLECTIS SA
1.39% | 14/02/2023 | 996 034 ( 1.39% ) | 3 M $ | 31/03/2024 |
Cargos activos de André Choulika
Empresas | Cargo | Inicio |
---|---|---|
CELLECTIS S.A. | Founder | 20/12/1999 |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Director/Board Member | 06/08/2013 |
Cellectis, Inc.
Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Part of Cellectis SA, Cellectis, Inc. engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers. The private company is based in New York, NY. André Choulika has been the CEO of the company since 2014. | Chief Executive Officer | 01/12/2014 |
Institut Pasteur
Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Director/Board Member | 01/06/2019 |
Cellectis Biologics, Inc. | Chief Executive Officer | 01/01/2019 |
Antiguos cargos conocidos de André Choulika.
Empresas | Cargo | Fin |
---|---|---|
Calyxt, Inc.
Calyxt, Inc. Miscellaneous Commercial ServicesCommercial Services Calyxt, Inc. is technology company. engages in delivering plant-based solutions. Its products include high oleic soybean oil, high fiber wheat, high oleic soybean meal, and low lignin alfalfa. The company was founded by Daniel F. Voytas and André Choulika on January 8, 2010 and is headquartered in Roseville, MN. | Founder | 06/07/2020 |
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Director/Board Member | - |
Formación de André Choulika.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CELLECTIS S.A. | Health Technology |
Empresas privadas | 7 |
---|---|
Institut Pasteur
Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Miscellaneous |
Université Pierre et Marie Curie | Consumer Services |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Commercial Services |
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Commercial Services |
Cellectis, Inc.
Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Part of Cellectis SA, Cellectis, Inc. engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers. The private company is based in New York, NY. André Choulika has been the CEO of the company since 2014. | Health Technology |
Calyxt, Inc.
Calyxt, Inc. Miscellaneous Commercial ServicesCommercial Services Calyxt, Inc. is technology company. engages in delivering plant-based solutions. Its products include high oleic soybean oil, high fiber wheat, high oleic soybean meal, and low lignin alfalfa. The company was founded by Daniel F. Voytas and André Choulika on January 8, 2010 and is headquartered in Roseville, MN. | Commercial Services |
Cellectis Biologics, Inc. |
- Bolsa de valores
- Insiders
- André Choulika